| Literature DB >> 21103879 |
P S Muether1, G Welsandt, T S Dietlein.
Abstract
We report a case of acute myopic recurrence in a 38-year-old patient in a state of panic with a condition corresponding to LASIK 4 months earlier. The patient had commenced topiramate treatment 1 week previously, which is an antiepileptic drug also approved for migraine treatment. The symptoms were due to a rare topiramate-induced side effect (SE) with ciliochoroidal effusion, anterior shift of the lens-iris diaphragm and induced myopia. Cessation of topiramate led to complete remission of this idiosyncratic reaction, however, the patient's anxiety was impressive. Ocular administration of Topiramat-SE should thus be clarified.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21103879 DOI: 10.1007/s00347-010-2276-7
Source DB: PubMed Journal: Ophthalmologe ISSN: 0941-293X Impact factor: 1.059